Based on the above understanding of CD18 biology and NASH-related inflammation, we hypothesized that CD18 deficiency would protect mice from hepatic inflammation and liver injury in an experimental model of steatohepatitis. The gene discussed is ITGB2; the disease is metabolic dysfunction-associated steatohepatitis.